We are grateful for the valuable support from clinicians and technicians of Bharati Vidyapeeth Medical College and Hospital. We thank Tushar Bhosale for sample collection and Rahul Patil for statistical analysis. We also thank Rahul Kadu and Shweta Chelluboina for BSL-3 lab support. The American Society of Tropical Medicine and Hygiene has waived the Open Access fee for this article due to the ongoing COVID-19 pandemic and has assisted with publication expenses.
World Health Organization , 2009. Clinical Management of COVID-19. WHO/2019-nCoV/clinical/2020.5.
Zhou F et al., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054–1062.
Liu X et al., 2020. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect 81: e95–e97.
Okba NMA et al., 2020. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis 26: 1478–1488.
Qu J , Wu C , Li X , Zhang G , Jiang Z , Li X , Zhu Q & Liu L. 2020. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis Apr 27: ciaa489.
Sun B et al., 2020. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect 9: 940–948.
al Liu W , 2020. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol 58: e00461–e20.
Burbelo PD , Riedo FX , Morishima C , Rawlings S , Smith D , Das S , Strich JR , Chertow DS , Davey RT , Cohen JI , 2020. Detection of nucleocapsid antibody to SARS-CoV-2 is more sensitive than antibody to spike protein in COVID-19 patients. J Infect Dis 222: 206–213.
Perera RA et al., 2020. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill 25: 2000421.
To KK et al., 2020. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 20: 565–574.
Zhao J et al., 2020. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 71: 2027–2034.
Tan W et al., 2020. Viral kinetics and antibody responses in patients with COVID-19. medRxiv March 26. Available at: https://doi.org/10.1101/2020.03.24.20042382
Shen L et al., 2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression. Emerg Microbes Infect 9: 1096–1101.
Liu X , Wang J , Xu X , Liao G , Chen Y , Hu C-H , 2020. Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect 9: 1269–1274.
Cohen BJ et al., 2007. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26: 59–66.
Saravanabalaji S , Tripathy AS , Dhoot RR , Chadha MS , Kakrani AL , Arankalle VA , 2009. Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e. Intervirology 52: 78–85.
- Search Google Scholar
- Export Citation
Saravanabalaji S Tripathy AS Dhoot RR Chadha MS Kakrani AL Arankalle VA 2009. Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e. Intervirology 52: 78– 85.
Ramdasi AY , Arya RP , Arankalle VA , 2014. Effect of pregnancy on Anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E. PLoS One 9: e103257.
- Search Google Scholar
- Export Citation
Ramdasi AY Arya RP Arankalle VA 2014. Effect of pregnancy on Anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E. PLoS One 9: e103257.
Wu F et al., 2020. Evaluating the association of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild COVID-19 in Shanghai, China. JAMA Intern Med 180: 1356–1362.
Rijkers G , Murk JL , Wintermans B , van Looy B , van den Berge M , Veenemans J , Stohr J , Reusken C , van der Pol P , Reimerink J , 2020. Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections. J Infect Dis 222: 1265–1269.
Liu L et al., 2020. High neutralizing antibody titer in intensive care unit patients with COVID-19. Emerg Microbes Infect 9: 1664–1670.
Wang P et al., 2020. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease. Emerg Microbes Infect 9: 2091–2093.
Quinti I et al.2020. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J Allergy Clin Immunol 146: 211–213.e4.
Duan K et al., 2020. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA 117: 9490–9496.
Rogers TF et al., 2020. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369: 956–963.